Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Bavencio 20 mg/mL concentrate for solution for infusion {black_triangle}

Active Ingredient:
avelumab
Company:  
Merck See contact details
ATC code: 
L01FF04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Bavencio 20 mg/ml concentrate for solution for infusion (avelumab) – Patient Alert Card

Patient Alert Card

{pdf_link}

Bavencio 20 mg/ml concentrate for solution for infusion (avelumab) – Patient Information Brochure

Patient Information Brochure - Important safety information to minimise the risk of immune-related adverse reactions

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Merck
Company image
Address
Merck Serono Ltd, 5 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, UK
Telephone
+44 (0)208 818 7200
Fax
+44 (0)208 818 7267
Medical Information Direct Line
+44 (0)208 818 7373
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)208 818 7274